Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Todd N who wrote (4240)	5/6/1998 12:42:00 PM
From: Steve Fancy	Read Replies (2) \| Respond to of 6136

Thanks Todd, I like to stay on top of what the analysts are saying, and have missed this so far today. Interestingly they have come in right in the middle of the two significant 12 month targets I'm aware of being 45 and 51. At this point, PaineWebber seems so far out of the ballpark, and has maintained their $65-$70 price target for so long, that I can't give them much weight any longer. The price target suggested in your post reinforces that 45-50 may be reasonable. Although this is still well off the 52-week high, represents a significant upside from where we're at. sf